compounded glp-1 fda medications are trending online, but not everything you hear is true. Your health deserves accurate information—not hype. Learn More: https://healthnothype.org/ #HealthNotHype #GLP1 #PatientSafety #HealthEducation #KnowTheFacts Compounded GLP 1 and Dual

Among the participants, 15,264 females (13.7%) had documented prescriptions for GLP-1 medications and 96,382 women (86.3%) had no documented exposure to GLP-1 drugs

The exclusion criteria that bar these patients from Bridge eligibility (on the logic that their plan already covers GLP-1s for their condition) creates a situation where patients with more severe underlying health profiles may face higher out-of-pocket costs than patients who qualify for Bridge access

Which specialist you need depends on the question

Semaglutide (Ozempic, Wegovy) may worsen diabetic retinopathy in patients with pre-existing retinal disease who experience rapid blood sugar improvements, but it does not directly damage eye structures

The GABAergic modulation ability of GLP-1RAs is more thoroughly studied in brain tissues and cells

The difference comes down to bioavailability and understanding that variable is the key to setting realistic expectations